Bridges J W
Ciba Found Symp. 1980;76:5-24. doi: 10.1002/9780470720592.ch2.
Drug-metabolizing enzymes function in the biotransformation of both endogenous and exogenous lipophilic compounds. Phylogenetic studies indicate that the drug-metabolizing enzymes were a late evolutionary development. Stimuli for the evolution of these enzymes were probably movement to a terrestrial environment, a diet of higher plants and an increasing tissue specialization, with a consequential need for the formation and inactivation of hormones, bile salts etc. Most drug-metabolizing enzymes exist in multiple forms. Some are concerned solely with the metabolism of a very limited range of endogenous lipids; others such as 'phenobarbitone-type cytochrome P-450' seem to be concerned mainly wih the metabolism of exogenous compounds. In mammals the liver and intestine have a major role in the biotransformation of exogenous compounds, whereas in other tissues the primary function of the drug-metabolizing enzymes appears to be the metabolism of endogenous lipids such as steroids, lipid-soluble vitamins and fatty acids.
药物代谢酶在内源性和外源性亲脂性化合物的生物转化中发挥作用。系统发育研究表明,药物代谢酶是进化后期才出现的。这些酶进化的刺激因素可能是向陆地环境的迁移、以高等植物为食以及组织专业化程度的提高,随之而来的是对激素、胆汁盐等的形成和失活的需求。大多数药物代谢酶以多种形式存在。有些仅与非常有限范围的内源性脂质的代谢有关;其他的,如“苯巴比妥型细胞色素P-450”,似乎主要与外源性化合物的代谢有关。在哺乳动物中,肝脏和肠道在外源性化合物的生物转化中起主要作用,而在其他组织中,药物代谢酶的主要功能似乎是类固醇、脂溶性维生素和脂肪酸等内源性脂质的代谢。